Monoclonal antibody (mAb) manufacturing must continually improve to keep up with increasing demands. To do this, biomanufacturers can deploy machine learning tools to augment traditional process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback